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Skeletal muscle satellite cells are considered to play a crucial role in muscle fiber
maintenance, repair and remodeling. Our knowledge of the role of satellite cells in muscle
fiber adaptation has traditionally relied on in vitro cell and in vivo animal models. Over
the past decade, a genuine effort has been made to translate these results to humans
under physiological conditions. Findings from in vivo human studies suggest that satellite
cells play a key role in skeletal muscle fiber repair/remodeling in response to exercise.
Mounting evidence indicates that aging has a profound impact on the regulation of
satellite cells in human skeletal muscle. Yet, the precise role of satellite cells in the
development of muscle fiber atrophy with age remains unresolved. This review seeks
to integrate recent results from in vivo human studies on satellite cell function in muscle
fiber repair/remodeling in the wider context of satellite cell biology whose literature is
largely based on animal and cell models.
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INTRODUCTION
Adaptation is broadly defined as a change in behavior, physiology or structure in response to a
changing environment. Adaptation in the context of skeletal muscle is often discussed as a change
in structure and function in response to an exercise stimulus. The nature of adaptation in skeletal
muscle in response to exercise is wholly dependent on the nature of the stimulus. For instance,
resistance exercise training is generally characterized by increases in muscle mass and muscle fiber
cross sectional area designed to resist the stress of lifting heavy loads. In contrast, endurance
exercise training is generally characterized by metabolic adaptations designed to enhance fuel
selection and ultimately resist fatigue. Although the concept of adaptation is rather simple, the
processes that govern adaptation are significantly complex and involve interactions between
multiple organs, tissues, cells, sub cellular organelles, and a plethora of coordinated signaling events.
Skeletal muscle stem cells, also known as satellite cells, are now thought to play a significant role in
the adaptive process.
Since their discovery by Mauro (1961) satellite cells have been identified as the main source
of new myonuclei in postnatal skeletal muscle tissue (Reznik, 1969; Moss and Leblond, 1970).
Abbreviations: FGF2, fibroblast growth factor 2; GAS, γ-interferon activation sequence; GDF11, growth differentiation
factor 11; HGF, hepatocyte growth factor; HGFA, hepatocyte growth factor activator; IGF-1, insulin-like growth factor-1;
IL-6, Interleukin 6; M-Cad, M-cadherin; MGF, mechano growth factor; MRF, myogenic regulatory factor; NCAM, neural
cell adhesion molecule; NSAID, non-steroidal anti-inflammatory drugs; Pax7, paired-box transcription factor 7; pSTAT3,
phosphorylated, signal transducer and activator of transcription 3; TGF-β, transforming growth factor-β.
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The term “satellite cell” was coined owing to the anatomical
location of these cells between the sarcolemma and basal lamina
of their associated muscle fiber. In adult muscle, satellite cells
typically reside in a quiescent state; however, upon stimulation
they activate, proliferate and/or differentiate. Myoblasts, the
progeny of satellite cells, can either fuse with each other
forming new myofibers, fuse to an existing muscle fiber donating
their nucleus to the fiber, or return to the quiescent state,
replenishing the resident pool of satellite cells through self-
renewal (Schmalbruch, 1976). The progression of the satellite
cell through the myogenic program is thought to be orchestrated
by the up- or down-regulation of the paired box transcription
factor 7 (Pax7) and the myogenic regulatory factors (MRFs)
(Seale et al., 2000). From both in vitro cell and in vivo animal
work it has been well-established that the up-regulation of Myf5
marks the earliest phase of myogenic commitment followed by
the concomitant expression of MyoD, which marks the majority
of newly activated satellite cells (Grounds et al., 1992; Smith et al.,
1994; Cornelison andWold, 1997; Cooper et al., 1999; Cornelison
et al., 2000). Following proliferation, terminal differentiation of
the satellite cell is believed to be initiated by the up-regulation
of MRF4 and myogenin (Grounds et al., 1992; Smith et al.,
1994; Yablonka-Reuveni and Rivera, 1994; Cornelison andWold,
1997; Cornelison et al., 2000), and down-regulation of Pax7
(Olguin and Olwin, 2004; Olguin et al., 2007). However, when
Pax7 expression remains elevated following proliferation, satellite
cells exit terminal differentiation, and return to the quiescent
state, thereby promoting self-renewal and maintenance of the
basal satellite cell pool (Olguin and Olwin, 2004; Olguin et al.,
2007).
Skeletal muscle satellite cells have been investigated using
numerous in vitro and in vivo animal models to assess their
role in muscle fiber maintenance, regeneration, and/or growth.
However, in recent years, substantial effort has been made to
translate these results from cell and animal work to the human
model. In human skeletal muscle, the function and regulation of
satellite cells is primarily investigated by using acute damaging or
non-damaging exercise as a form of stress to mobilize the satellite
cell population. These studies provide crucial information on
the underlying mechanisms of satellite cell function under
physiological conditions in humans. In this review we will discuss
the identification of satellite cells in human skeletal muscle and
provide a “signature” for the resting satellite cell pool. In addition,
we will discuss the regulation of satellite cells during muscle
fiber repair and remodeling in human skeletal muscle. We will
describe factors currently considered to play a role in the process
of satellite cell activation, proliferation, and/or differentiation in
both animals and humans. Finally, we will discuss the impact of
aging on satellite cell number and function and suggest future
study directions.
SATELLITE CELL IDENTIFICATION IN
HUMAN SKELETAL MUSCLE
Due to its anatomical location, identification of satellite cells
originally relied on electron microscopy, and all cells that were
located beneath the basal lamina, and above the sarcolemma
of a myofiber were considered satellite cells (Mauro, 1961).
However, relatively recent advances in immuno-staining against
various molecular markers has made the identification of satellite
cells possible using light and/or immunofluorescent microscopy.
In human skeletal muscle, the first antibody that was used to
identity satellite cells by light microscopy was a glycoprotein
called Leu-19 (Schubert et al., 1989). In this study satellite
cells were identified by a “spike-like projection” of the Leu-19
antigen, which was not found around myonuclei and, secondly,
they were localized beneath the basal lamina (Schubert et al.,
1989). Subsequent studies showed that the Leu-19, neural cell
adhesion molecule (NCAM) and, CD56 antigens have identical
immunohistological labeling and staining patterns (Lanier et al.,
1989; Illa et al., 1992; Mechtersheimer et al., 1992). The
NCAM/CD56 antigen has been most frequently used to identify
satellite cells in human skeletal muscle cryosections (Kadi et al.,
1999; Kadi and Thornell, 2000; Renault et al., 2002; Charifi et al.,
2003; Crameri et al., 2004; Kadi et al., 2004a,b,c; Dreyer et al.,
2006; Kadi et al., 2006; Olsen et al., 2006; Petrella et al., 2006;
Crameri et al., 2007; Mackey et al., 2007a,b; Verdijk et al., 2007;
O’Reilly et al., 2008; Petrella et al., 2008; Verney et al., 2008;
Lindstrom and Thornell, 2009; Mackey et al., 2009; Mikkelsen
et al., 2009; Verdijk et al., 2010; Mackey et al., 2011a; Snijders
et al., 2011, 2012; Theriault et al., 2012; Verdijk et al., 2012;
Cermak et al., 2013; Leenders et al., 2013; Wernbom et al., 2013;
Dirks et al., 2014a,b; Mackey et al., 2014; Snijders et al., 2014a;
Theriault et al., 2014; Verdijk et al., 2014). Cells located at the
periphery of myofibers, showing NCAM/CD56 staining around
a nucleus, are considered satellite cells. Although the use of
NCAM/CD56 is considered to be a reliable molecular marker to
identify satellite cells in human skeletal muscle, this membrane
bound protein is also expressed in myoblasts, myotubes, and
muscle fibers during development and/or regeneration (Illa et al.,
1992). Furthermore, NCAM/CD56 has been documented to stain
positive along unmyelinated intramuscular nerves, at the surface
of motor nerve terminals and Schwann cells (Cashman et al.,
1987; Mechtersheimer et al., 1992). Alternative markers used
to identify satellite cells in human skeletal muscle are the cell
adhesion protein M-cadherin (M-Cad) (Reimann et al., 2004;
Sajko et al., 2004), c-Met (Lindstrom et al., 2010; McKay et al.,
2010), and Pax7 (Verdijk et al., 2007; Lindstrom and Thornell,
2009; Mackey et al., 2009; Mikkelsen et al., 2009; McKay et al.,
2010). In animal muscle, M-Cad is a well-established marker
of satellite cells (Irintchev et al., 1994). Irintchev et al. (1994)
showed that virtually allM-Cad positive satellite cells co-localized
with NCAM in mouse muscle. Interestingly, whereas the most
intense staining of NCAM/CD56 is typically observed on the side
of the satellite cell facing the muscle, M-Cad is also observed
to stain between the satellite cell and parent muscle fiber. To
date, only a few studies have used M-Cad as a molecular marker
to successfully detect satellite cells in human skeletal muscle
(Reimann et al., 2004; Sajko et al., 2004). To what extent M-Cad
and NCAM/CD56 co-localize in human skeletal muscle remains
unknown.
As a receptor for hepatocyte growth factor (HGF), c-Met has
been shown to be present in both quiescent and activated satellite
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cells (Cornelison and Wold, 1997). Previous studies have used
c-Met to identify human myogenic cells in vitro and in vivo
as a total satellite cell marker (De Luna et al., 2004; Antunes-
Foschini et al., 2006). So far, two studies have investigated
the viability of the c-Met antigen to identify satellite cells in
human skeletal muscle. In resting muscle biopsy samples from
healthy young individuals, our laboratory has shown that the
number of c-Met+/Pax7+ cells is significantly lower compared
with NCAM+ or PAX7+ or NCAM+/PAX7+ cells (McKay et al.,
2010). This would suggest that either c-Met expression is very
low in quiescent human satellite cells or they represent a sub-
population of the quiescent satellite cell pool. In addition, c-
Met has also been shown to mark small blood vessels, myofiber
membranes, and mononuclear interstitial cells in human skeletal
muscle (Lindstrom et al., 2010). Both these in vivo human studies
(Lindstrom et al., 2010; McKay et al., 2010) concluded that c-
Met should not be considered as a reliable marker for satellite
cell enumeration in human muscle cryosections.
Unlike NCAM, M-Cad, and c-Met, Pax7 is known to be
expressed in the nuclei of myogenic progenitor cells during
development and is thought to be exclusively expressed in
satellite cells of mature muscle (Seale et al., 2000; Oustanina
et al., 2004; Kuang and Rudnicki, 2008). In animal studies, the
Pax7 antigen is the most widely used marker to identify satellite
cells (Olguin and Olwin, 2004; Kuang et al., 2006; Relaix et al.,
2006; Zammit et al., 2006; Day et al., 2007; Ishido et al., 2009;
Lepper et al., 2011; McCarthy et al., 2011; Murphy et al., 2011;
Sambasivan et al., 2011; Jackson et al., 2012) and has been
proposed to be the most reliable marker for satellite cells in
mouse muscle (Kuang and Rudnicki, 2008; Zammit, 2008). In
the past decade, an increasing number of human studies have
utilized the Pax7 antibody for the identification of skeletal muscle
satellite cells in vivo (McLoon and Wirtschafter, 2003; Reimann
et al., 2004; Verdijk et al., 2007; McKay et al., 2008; Mackey
et al., 2009; McKay et al., 2009; Kottlors and Kirschner, 2010;
McKay et al., 2010; Mackey et al., 2011a; Toth et al., 2011; McKay
et al., 2012; Menon et al., 2012; Nielsen et al., 2012; Theriault
et al., 2012; Walker et al., 2012; Bankole et al., 2013; Cermak
et al., 2013; Delhaas et al., 2013; Joanisse et al., 2013; McKay
et al., 2013; Suetta et al., 2013; Bellamy et al., 2014; Farup et al.,
2014a,b; Fry et al., 2014a; Grubb et al., 2014; Kern et al., 2014;
Mackey et al., 2014; Snijders et al., 2014b,c; Theriault et al.,
2014). Reimann et al. (2004) compared M-Cad and Pax7 in
biopsies taken from healthy and pathological human muscle. As
M-Cad staining identified more cells in the satellite cell position
than Pax7, the authors of this study advised against the use of
Pax7 as an individual marker of satellite cells in human skeletal
muscle. However, to date a widely accepted M-cad antibody is
not available and more research into the characteristics of M-cad
on human muscle satellite cells may be warranted. A number
of other studies have investigated the use of NCAM/CD56
compared with Pax7 for satellite cell enumeration in humans
(Verdijk et al., 2007; Lindstrom and Thornell, 2009;Mackey et al.,
2009; Mikkelsen et al., 2009; McKay et al., 2010). Whereas, some
studies show higher percentage (∼5%) of cells in the satellite cell
position expressing NCAM compared with Pax7 (Lindstrom and
Thornell, 2009; Mackey et al., 2009; Mikkelsen et al., 2009), we
have reported a slightly higher number of Pax7+ compared to
NCAM+/CD56+ satellite cells in human muscle cross-sections
(Verdijk et al., 2007; McKay et al., 2010). Although the reported
differences between the number of Pax7+ and NCAM+/CD56+
satellite cells are small, some of this discrepancymay be attributed
to the fact that NCAM/CD56 has also been shown to mark
satellite cells committed to differentiation (Capkovic et al., 2008).
In addition, in vitro studies indicate that NCAM is mainly
involved in early myoblast differentiation of cell-cell fusion
leading to enhanced myotube formation (Suzuki et al., 2003).
The observation that NCAM/CD56 is expressed to a higher
degree in terminal differentiating satellite cells may explain
why studies have reported NCAM+/PAX7− cells in human
muscle biopsy samples (Lindstrom and Thornell, 2009; Mackey
et al., 2009; Mikkelsen et al., 2009). As the majority of satellite
cells are believed to progress toward terminal differentiation
they may down-regulate Pax7 and up-regulate NCAM to allow
for differentiation to occur (Capkovic et al., 2008; Kuang
and Rudnicki, 2008). Hence, depending on the muscle biopsy
sampling time point, the satellite cell pool may differentially
express NCAM/CD56, and Pax7.
The use of any single molecular maker to identify satellite cells
in human muscle cryosections for enumeration may inherently
underestimate the total satellite cell pool size. Nonetheless, the
use of laminin to identify the satellite cell niche appears to be
critical, especially when using NCAM/CD56 as a satellite cell
marker (Lindstrom and Thornell, 2009; Lindstrom et al., 2010).
Multiple labeling (Pax7 and NCAM) will most likely provide the
optimal identification of the satellite cell pool size at rest and in
response to stimulation. However, the use of multiple nuclear
markers in immunohistochemistry can become very difficult,
especially in combination with additional cellular markers for
satellite cell activation status.
Irrespective of the satellite cell marker used, it is important to
note that satellite cell content cannot be reliably estimated on a
small number of muscle fibers. Mackey et al. (2009) have shown
that at least 50 type I and 75 type II muscle fibers are required
to make a reliable estimation of fiber type specific satellite cell
content in healthy young men. Whether the same number of
muscle fibers is enough to make a reliable estimation of satellite
cell content in other populations remains to be established,
especially as satellite cell content has been suggested to decrease
with advancing age (Verney et al., 2008; Carlson et al., 2009;
Verdijk et al., 2009, 2010, 2012, 2014; McKay et al., 2012, 2013;
Leenders et al., 2013; Suetta et al., 2013; Mackey et al., 2014;
Snijders et al., 2014c). Counting all satellite cells in a muscle
section (thereby increasing the number of fibers included in the
analyses) is preferred as this will prevent subjective selection
of the area being assessed. Furthermore, recent studies have
emphasized the need for muscle fiber type specific analyses of
satellite cell number. Resting satellite cell content has been shown
to vary between muscle fiber types in both healthy and diseased
populations (Verdijk et al., 2007, 2009, 2012; Verney et al., 2008;
Snijders et al., 2011, 2014c; McKay et al., 2012; Suetta et al., 2012;
Bankole et al., 2013). Furthermore, satellite cells have been shown
to respond differently during post-exercise recovery depending
on the muscle fiber type in which they are located (McKay et al.,
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2012; Cermak et al., 2013; Joanisse et al., 2013; Fry et al., 2014a;
Snijders et al., 2014c).
When evaluating the satellite cell response to a stimulus, cell
cycle analysis is of particular importance. Different molecular
markers have been used to assess the changes in satellite cell
activation status in response to various stimuli. The Ki-67 antigen
is regarded as a marker of proliferating cells and is expressed
during the mid-G1phase, with increased expression during the
S and G2 phase and peaking in theM phase of the cell cycle
(Gerdes et al., 1984). Whereas, some do (Mackey et al., 2009)
others do not (Snijders et al., 2012; Cermak et al., 2013; Mackey
et al., 2014) show a change in the number of Ki-67+ satellite
cells after an anabolic stimulus in healthy young men. This
discrepancy can most likely be explained by the relative short
half-life of Ki-67, which makes the timing of muscle biopsy
sampling critical to detect a change. Similarly, the proliferating
cell nuclear antigen (PCNA) has been used to distinguish “active”
from “non-active” satellite cells in human skeletal muscle (McKay
et al., 2009; Cermak et al., 2013). However, PCNA is expressed
in the nuclei of cells only in the DNA synthesis phase (S-
phase) and late G1 phase, not the G2 and/orM phase of the
cell cycle, and therefore may underestimate the number of active
cells in a muscle cross-section. As both Ki-67 and PCNA are
apparent in the nucleus during multiple or all stages of the cell
cycle it does not discriminate between cells in different phases
of the cell cycle. Flow cytometry is routinely used to analyse
cells based on multiple antigen labeling in vitro and is used
extensively in stem cell research to purify rare cell populations
from a larger cellular milieu. Flow cytometry utilizes many DNA-
specific markers such as Propidium Iodide to allow for a more
precise measurement of cell cycle kinetics based on the DNA
content of each cell. Hence, this allows for the description of
the proliferation characteristics of satellite cells as they were
in vivo, allowing for the determination of the number of cells
in different phases of the cell cycle. Using flow cytometry, our
laboratory has recently demonstrated that the number of satellite
cells in G0/G1 of the cell cycle increases significantly during
24 and 48 h of recovery from a single bout of resistance and
eccentric exercise, respectively, suggesting that within 24 h a
proportion of satellite cells completed at least one round of cell
division (McKay et al., 2010, 2012). This finding was supported
by a significant increase in the number of Pax7+ cells per
milligram tissue at 24 (McKay et al., 2010) and 48 h (McKay et al.,
2012) after a single bout of eccentric or resistance type exercise,
respectively. Furthermore, we have shown a significant increase
in the number of satellite cells in the S-phase and G2/M phase
of the cell cycle during the first 48 h of post-exercise recovery
(McKay et al., 2010, 2012). Hence, flow cytometry is an objective,
reproducible and precise measurement to investigate satellite
cell cell-cycle kinetics in human skeletal muscle in response to
exercise (McKay et al., 2010, 2012). Flow cytometry may also
offer an objective way of sub-classifying the satellite cell pool
based on different cell surface markers such as NCAM and
M-cad.
Over the last decade, a genuine effort has been made to
further elucidate the factors that control satellite cell function
in human skeletal muscle. The co-localization of numerous
molecular markers with satellite cells during muscle fiber repair
FIGURE 1 | Proportion (±SEM) of satellite cell pool positive for
interleukin-6 (IL-6), myostatin (MSTN), phosphorylated signal
transducer and activator of transcription 3 (pSTAT3), cMyc, Myogenic
Differentiation (MyoD), Delta Like 1 (DLK1), Proliferating cell nuclear
antigen (PCNA), Ki-67, determined by immunohistochemistry, and
“active” (G2/M phase) and “quiescent” (G0/G1 phase) satellite cells
assessed by flow cytometric in resting vastus lateralis muscle from
healthy young men (combined data from O’Reilly et al., 2008; McKay
et al., 2008, 2009, 2010, 2012, 2013; Toth et al., 2011; Snijders et al.,
2012, 2014b,c; Cermak et al., 2013; Bellamy et al., 2014).
and remodeling has provided us with crucial knowledge on the
underlying mechanisms of satellite cell function in healthy and
more compromised populations. Subsequently, we were able to
construct a (partial) “signature” of a quiescent skeletal muscle
satellite cell in healthy young men based on immunofluorescent
and flow cytometric analysis (Figure 1). Next, we will discuss the
various factors proposed to play an important role in satellite cell
activation, proliferation, and differentiation in human skeletal
muscle.
THE ACUTE SATELLITE CELL RESPONSE
In humans, the skeletal muscle adaptive response after a single
bout of exercise is the most frequently used model to evaluate
the regulation of satellite cell function. In this model, volunteers
perform a single bout of exercise and percutaneous muscle
biopsies are collected before and at a single or multiple time
points during the hours/days of post-exercise recovery. Various
modes of exercise are used to investigate different functions
of human satellite cells during muscle fiber adaptation. A
single bout of unaccustomed eccentric exercise (e.g., muscle
lengthening contractions) is the most widely used model to
induce (ultra) structural damage to determine the role of satellite
cells in muscle fiber repair. From various animal studies it
has been well-established that skeletal muscle satellite cells are
essential for muscle fiber repair and/or regeneration (Lepper
et al., 2011; McCarthy et al., 2011; Murphy et al., 2011;
Sambasivan et al., 2011). Likewise, in human skeletal muscle,
robust changes in satellite cell number are typically observed
in the first few days after performing a single bout of eccentric
exercise (Crameri et al., 2004; Dreyer et al., 2006; McKay et al.,
2008, 2009; O’Reilly et al., 2008; Mikkelsen et al., 2009; Toth et al.,
2011; Cermak et al., 2013; Farup et al., 2014a; see Table 1). By
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TABLE 1 | Change in satellite cell content in response to a single bout of eccentric (damaging) exercise.
Publication Sex Age N Exercise protocol Fiber type Pre 1h 3h 4h 24h 48h 72h 96h 120h 196h
Cermak et al., 2013 M 23 ± 1 8 10 sets 30 reps at −180
deg/s
Mixed 0.091 25%
I 0.093 0%
II 0.085 73%*
Crameri et al., 2004 M 25 ± 3 8 50 one legged drop down
jumps
8 sets 10 reps at −30 deg/s
8 sets 10 reps at −120
deg/s
Mixed NA 146% 192%* 168%*
Dreyer et al., 2006 M 23–35 10 6 sets 16 reps at −60 deg/s Mixed 0.070 141%*
M 60–75 10 6 sets 16 reps at −60 deg/s Mixed 0.070 51%*
Hyldahl et al., 2014 M 23 ± 2 7 196 at reps at −180 deg/s Mixed 0.101 25%
I 0.080 30%
II 0.106 25%
McKay et al., 2009 M 22 ± 1 8 10 sets 30 reps at −180
deg/s
Mixed 0.147 73% 155%* 185%* 108%*
McKay et al., 2010 M 21 ± 2 12 10 sets 30 reps at −180
deg/s
Mixed 0.133 36%*
Mikkelsen et al., 2009 M 23 ± 3 8 200 reps at −120 deg/s Mixed 0.070 96%*
O’Reilly et al., 2008 M 21 ± 2 8 10 sets 30 reps at −180
deg/s
Mixed 0.057 5% 138%* 148%* 119%*
Toth et al., 2011 M 21 ± 2 12 10 sets 30 reps at −180
deg/s
Mixed 0.155 15% 17% 27%*
This table provides an overview of studies that have assessed the change in muscle fiber satellite cell content in response to a single bout of eccentric (damaging) exercise in both
young and older adults. Type I, type I muscle fibers; Type II, type II muscle fibers; Mixed, mixed muscle fibers. Pre value is the average number of satellite cells reported per muscle fiber.
*Significantly different compared to baseline value.
combining various data sets from previous studies from our lab
(McKay et al., 2008, 2009, 2010; Toth et al., 2011) we constructed
a comprehensive timeline on the change in whole muscle satellite
cell number during the first 5 days after a single bout of eccentric
exercise in healthy young men (n = 52; Figure 2). An increase
in satellite cell number becomes apparent at 24 h, and peaks
at 72 h of post-exercise recovery. Although most studies have
reported the changes in satellite cell content in whole muscle
(i.e., in a non fiber type-specific manner), high-force eccentric
exercise is generally associated with more selective recruitment
of type II muscle fibers (Nardone and Schieppati, 1988; Nardone
et al., 1989), and/or type II muscle fiber damage (Friden et al.,
1983; Vijayan et al., 2001). Accordingly, Cermak et al. (2013)
reported that satellite cell number increased specifically in the
type II muscle fibers after performing 300 eccentric contractions
in healthy young men. This shows that satellite cells are able to
respond in a fiber type specific manner.
Satellite cell function can also be evaluated in response
to non-damaging exercise (e.g., single session of resistance,
endurance, or combined exercise). Likewise, we (McKay et al.,
2012, 2013; Snijders et al., 2014b,c) as well as others (Mackey
et al., 2007b; Walker et al., 2012; Wernbom et al., 2013) have
reported large changes in satellite cell content in response to a
single bout of resistance or combined exercise in humans (see
Tables 2, 3). Given the substantial expansion of the satellite
cell population in the immediate post-exercise recovery period,
the single-bout-of-exercise model has been routinely used to
FIGURE 2 | Mean (±SEM) number of satellite cells (mixed muscle)
expressed as a percentage of total myonuclei before and 1, 3, 4, 24, 72,
and 120h after a single bout of eccentric exercise in healthy young
men (n = 52; combined data from McKay et al., 2008, 2009, 2010; Toth
et al., 2011).
evaluate potential factors important in directing satellite cells
through the myogenic program. A number of growth factors
and inflammatory cytokines released from skeletal muscle,
surrounding cells and/or other tissues following exercise have
been suggested to play a crucial role in satellite cell activation,
proliferation, and/or differentiation during muscle fiber repair
and remodeling in humans (Figure 3).
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TABLE 2 | Change in satellite cell content in response to a single bout of resistance (non-damaging) exercise.
Publication Sex Age N Exercise protocol Fiber type Pre 3h 6h 12h 24h 48h 72h
Bellamy et al., 2014 M 18–35 23 4 sets 8 reps LP-LE-CP-LC
(80% 1 RM)
I 0.107 22% 17%
II 0.113 34% 31%*
Hyldahl et al., 2014 M 24 ± 1 7 351 concentric contractions at
reps at 60 deg/s
Mixed 0.099 3%
I 0.107 −11%
II 0.100 17%
McKay et al., 2012 M 21 ± 3 10 4 sets 8 reps LE-LP (80% 1 RM) I 0.059 44% 46%*
II 0.095 26% 44%*
M 70 ± 4 10 4 sets 8 reps LE-LP (80% 1 RM) I 0.060 10% 62%
II 0.050 34% 6%
McKay et al., 2013 M 21 ± 3 10 4 sets 8 reps LE-LP (80% 1 RM) Mixed 0.138 5% 20%* 33%*
M 70 ± 4 10 4 sets 8 reps LE-LP (80% 1 RM) Mixed 0.092 –1% 15% 29%
Snijders et al.,
2014c
M 22 ± 1 10 10 sets 8 reps LE-LP (80% 1
RM)
I 0.094 14%* 19% 42%* 49%*
II 0.102 1 % 14% 34%* 48%*
M 73 ± 1 10 10 sets 8 reps LE-LP (80% 1
RM)
I 0.078 10%* 22% 40%* 45%*
II 0.077 -5 % 1% 8% 34%*
Walker et al., 2012 M 27 ± 2 5 8 sets 10 reps LE (70% 1 RM) Mixed 0.068 −13% 157%*
M 70 ± 2 6 8 sets 10 reps LE (70% 1 RM) Mixed 0.062 −1% 6%
F 27 ± 2 5 8 sets 10 reps LE (70% 1 RM) Mixed 0.051 7% 21%
F 70 ± 2 5 8 sets 10 reps LE (70% 1 RM) Mixed 0.032 115% 146%
This table provides an overview of studies that have assessed the change in muscle fiber satellite cell content in response to a single bout of resistance (non-damaging) exercise in both
young and older adults. Type I, type I muscle fibers; Type II, type II muscle fibers; Mixed, mixed muscle fibers; LP, leg press; LE, leg extension; LC, leg curl; CR, calf raises. Pre value is
the average number of satellite cells reported per muscle fiber. *Significantly different compared to baseline value.
TABLE 3 | Change in satellite cell content in response to a single bout of various other exercise modalities.
Publication Sex Age N Exercise protocol Fiber type Pre Post 1 h 9h 24h 48h 192h
COMBINED EXERCISE
(Snijders et al., 2012) M 20 ± 1 8 4× 5min 65% Wmax + 4× 45%
Wmax
Whole-body RT (65% 1 RM)
I 0.080 3% 26%
II 0.066 9% 24%
BLOOD FLOW RESTRICTED EXERCISE
(Wernbom et al., 2013) M and F 22 ± 3 6 vs. 1 5 sets until failure (30% 1 RM) Mixed 0.200 36%* ±43%* ±48%*
ENDURANCE EXERCISE
(Mackey et al., 2007b) M 25 ± 3 36 km run Mixed NA 27%*
This table provides an overview of studies that have assessed the change in muscle fiber satellite cell content in response to a single bout of various other exercise modalities. Type I,
type I muscle fibers; Type II, type II muscle fibers; Mixed, mixed muscle fibers. Pre value is the average number of satellite cells reported per muscle fiber. *Significantly different compared
to baseline value.
SATELLITE CELL REGULATORS:
Insulin-like Growth Factor-1 (IGF-1)
IGF-1 is a circulating growth factor that is produced and released
systemically by the liver and locally by the muscle. Three spliced
variants of IGF-1 have been described in skeletal muscle (i.e.,
IGF-1Ea, IGF-1Eb, and IGF-1Ec) and each has been hypothesized
to contribute to some extent to muscle fiber regeneration
(Rotwein et al., 1986; Yang et al., 1996; Chakravarthy et al., 2000).
In vitrowork has demonstrated that C2C12 myoblasts proliferate
when exposed to either IGF-1Ec [also known as mechano growth
factor (MGF)], or IGF-1Ea (Yang and Goldspink, 2002). In
contrast, C2C12 myoblasts show impaired differentiation to
MGF, but not with exposure to IGF-1Ea (Yang and Goldspink,
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2002). Consistent with these results, animal studies have reported
that MGF mRNA expression in muscle increases as early as 24 h
after mechanical damage, however, IGF-1Ea is only elevated after
5–10 days of recovery (Hill and Goldspink, 2003; Hill et al., 2003).
Similarly, muscle MGF mRNA expression has been shown to
be increased significantly, with no changes in IGF-1Ea mRNA
expression, approximately 2 h after performing eccentric cycle
ergometry in healthy, young men (Hameed et al., 2008). Hill
et al. (2003) suggest that MGF is related to the activation of
satellite cells, while IGF-1Ea is related to an increased need
for muscle protein synthesis in the late phase of satellite cell
differentiation. Recent work from our lab in healthy, young
men supports this notion. We have observed a strong temporal
relationship between MGF and Myf5, a known driver of satellite
cell proliferation, mRNA abundance in whole skeletal muscle
during recovery from eccentric exercise (McKay et al., 2008).
In contrast, we found that IGF-1Ea expression was strongly
correlated with Mrf4 expression, a MRF known for its role in
satellite cell differentiation (McKay et al., 2008). This was later
confirmed in human muscle tissue at the protein level (Philippou
et al., 2009), further supporting the temporal association of
IGF-1 splice variants with the myogenic program. Interestingly,
Hellsten et al. (1996) have reported an increase in the number
of IGF-1+ cells located in the satellite cell position after 7 days
of intense military training, which included 150 km of terrain
marching carrying a 30-kg load. However, as no co-localization
with a satellite cell marker was performed, the authors could
not exclude that a proportion of these “spindle shaped IGF-1
immunoreactive cells” may have been activated fibroblasts or
inflammatory cells. With the use of a pan-IGF-1 antibody we
have more recently been able to show that IGF-1 can indeed co-
localize with Pax7+ satellite cells in human muscle cross-sections
(Grubb et al., 2014). Furthermore, whereas no IGF-1 and Pax7
co-localization was observed in resting muscle biopsy samples,
themajority of satellite cells were reported to be IGF-1+ 24 h after
300 high-velocity maximal eccentric contractions (McKay et al.,
2008). This is further supported and consistent with the timing
of the observed change in IGF-1 splice variant mRNA expression
after eccentric exercise in healthy, young men (Bamman et al.,
2001; Hameed et al., 2008; McKay et al., 2008). Overall, both
animal and human studies provide substantial evidence that IGF-
1 plays an important role in skeletal muscle fiber repair which
may, in part, include satellite cell activation, proliferation, and
differentiation.
Hepatocyte Growth Factor (HGF)
HGF is a stromal mesenchymal-derived growth factor initially
named for its mitogenic properties in the liver. In response to
tissue damage, HGF is activated in the cytosol through cleavage of
its pro-peptide serine proteaseHGF activator (HGFA) (Miyazawa
et al., 1996; Tjin et al., 2004), which in itself is activated from
its zymogen form (Shimomura et al., 1993). HGF is known to
activate quiescent satellite cells by binding to its receptor c-Met,
which is localized to the satellite cell membrane (Shimomura
et al., 1993; Allen et al., 1995; Tatsumi et al., 1998; Yamada et al.,
2010). Administration of recombinant HGF into animal muscle
results in an increase in the number of BrdU+ orMyoD+ satellite
cells and a reduction in muscle fiber formation (Tatsumi et al.,
1998; Miller et al., 2000), which supports the notion that HGF is
a potent stimulator of satellite cell activation and proliferation,
but not differentiation (Allen et al., 1995; Anastasi et al., 1997;
Gal-Levi et al., 1998; Tatsumi et al., 1998, 2006a; Miller et al.,
2000; Li et al., 2009). In addition, it has been demonstrated that
when myoblasts are exposed to stretch, HGF is released from
the extracellular tethering, suggesting an autocrine/paracrine
function of HGF (Tatsumi et al., 2001, 2002, 2006a,b; Yamada
et al., 2010). In contrast, there is very little data on the role of HGF
in satellite cell function during repair/regeneration in human
skeletal muscle. To our knowledge, only one study has assessed
HGF in relation to satellite cell function during muscle fiber
repair in humans. In this study we reported a substantial increase
in satellite cell number accompanied by a concomitant increase
in HGFA protein content 24 h following a single bout of eccentric
exercise in healthy young men (O’Reilly et al., 2008). In addition,
an (non-significant) increase in active HGF was observed during
the first 24 h of post-exercise recovery. Interestingly, in the same
study we found that serum HGF was significantly elevated at
4 h after the muscle damage protocol (O’Reilly et al., 2008).
Although the rise of HGF in circulation gives no information
as to the origin of HGF, it is conceivable that the increase
in serum HGF represents a systemic response (non-muscular)
to localized muscle damage. This would be consistent with
experiments in rats demonstrating that HGF mRNA and protein
expression are upregulated in non-muscle tissue following injury
of skeletal muscle (Suzuki et al., 2002). Furthermore, HGF may
be carried to the site of injury by granulocytes, known to increase
in number during the inflammatory response to muscle fiber
damage (Ohnishi et al., 2006). On the other hand, HGF levelsmay
also rise simply as a result of the muscle damage itself, as proteins
may leak into circulation by disruption of skeletal muscle fiber
membranes. Future studies should aim to further establish the
origin of circulating HGF levels following muscle fiber damage
and its precise role in satellite cell function in human skeletal
muscle.
Interleukin 6 (IL-6)
Traditionally, Interleukin 6 (IL-6) was considered to be an
inflammatory cytokine (Kishimoto, 2005). However, it is well-
established that IL-6 is also produced by skeletal muscle in
response to exercise (see also review Pedersen and Febbraio,
2008). As such, IL-6 is also referred to as a “myokine” (Keller
et al., 2003; Pedersen and Febbraio, 2008). An exercise induced
increase in circulating levels of IL-6 has been observed to enhance
fat-oxidation, improve insulin-stimulated glucose uptake, and
at low levels has an anti-inflammatory effect (Pedersen and
Febbraio, 2008). In addition, animal studies have suggested
that IL-6 may also play a significant role in satellite cell
mediated muscle fiber growth. IL-6 knock-out mice show a
blunted muscle fiber hypertrophic response and less satellite
cell mediated myonuclear accretion compared to wild-type mice
following overload induced muscle hypertrophy (Serrano et al.,
2008). In addition, it was reported that satellite cells from IL-
6 knock-out mice have a reduced proliferative capacity, both
in vitro as well as in vivo, which was shown to be related
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to a loss of IL-6 mediated signal transducer and activator of
transcription 3 (STAT3) signaling (Serrano et al., 2008). STAT3
is a downstream target of IL-6 (Levy and Lee, 2002; Trenerry
et al., 2008), and upon IL-6 binding to the IL-6Rα receptor,
JAK2 is phosphorylated and initiates the phosphorylation of
STAT3. This leads to the subsequent homodimerization and
translocation of pSTAT3 to the nucleus (Rawlings et al., 2004).
In the nucleus, pSTAT3 binds to the γ-interferon activation
sequence (GAS) element where it promotes the transcription of
downstream genes that are responsible for a variety of cellular
functions including proliferation, migration and the prevention
of apoptosis (Ivanova et al., 2004; Serrano et al., 2008). STAT3 is
known to regulate a number of its upstream signaling cascade
members including IL-6, GP130, IL-6Rα, and suppressor of
cytokine signaling 3 (SOCS3). The STAT3 pathway is regulated
in a negative feedback loop through interaction with JAK2.
SOCS3 can bind phosphotyrosines on JAK2 and physically
block STAT3 from binding to JAK2. In addition, SOCS3 can
recruit ubiquitin-transferases leading to the ubiquitination and
degradation of JAK2 (Rawlings et al., 2004). Previously, we
have shown that the IL-6Rα receptor is expressed on human
skeletal muscle satellite cells (McKay et al., 2009, 2013; Toth
et al., 2011). Whereas, IL-6 is virtually non-detectable in the
resting/undamaged state, we have shown a substantial rise in
the proportion of satellite cells positive for IL-6 (approximately
60–80%) as early as 3 and up to 24 h after a single bout of
eccentric exercise in healthy young men (McKay et al., 2009;
Toth et al., 2011). Interestingly, in these studies, satellite cell
content increased significantly at 24 h and peaked 72 h following
exercise, at which time the number of IL-6+ satellite cells had
already decreased to baseline levels (McKay et al., 2009; Toth
et al., 2011). In addition, Toth et al. (2011) reported a significant
increase in the number of pSTAT3+ satellite cells 1, 3, and 24 h
after a single bout of eccentric exercise. Moreover, the increase
in the number of pSTAT3+ satellite cells was accompanied by
a concomitant increase in the number of cMyc+/Pax7+ cells
24 h post-exercise. cMyc is a critical regulator of the cell cycle,
responsible for the transition from G1 to S phase (Dang, 1999)
and is upregulated in response to IL-6 signaling (Nabata et al.,
1990) in a STAT3 induced GP130mediatedmanner (Kiuchi et al.,
1999). The early increase in pSTAT3+ cells provides temporal
evidence that following a bout of damaging exercise, STAT3 is
phosphorylated leading to downstream signaling events resulting
in the proliferation of human satellite cells. This is in accordance
with a recent study in animals showing that conditional ablation
of STAT3 in satellite cells resulted in an expansion of the satellite
cell pool size during regeneration, but comprised myogenic
differentiation, preventing the contribution of these cells to
regenerating myofibers (Tierney et al., 2014). Thus, it appears
that IL-6 is a critical signaling molecule, contributing to the
coordination of satellite cell function in vivo. This theory is
further supported by data from human studies that report
an inhibition of the satellite cell response to exercise-induced
muscle damage via the administration of non-steroidal anti-
inflammatory drugs (NSAID) (Mackey et al., 2007b; Mikkelsen
et al., 2009), which block the inflammatory cascades responsible
for cytokine production. Furthermore, the temporal nature of
the IL-6 response has been suggested to be essential for an
appropriate satellite cell response. Following exercise, IL-6 is
systemically released in a temporal manner, increasing rapidly
and remaining elevated for a few hours to a few days (Serrano
et al., 2008; McKay et al., 2009). This temporal increase in
IL-6 appears to have a positive impact on muscle health,
augmenting glucose uptake and muscle stem cell function. A
chronic elevation of circulating IL-6 observed in disease states
appears to be detrimental, impairing muscle protein synthesis,
and contributing to the loss of skeletal muscle mass (Haddad
et al., 2005). In addition to the temporal expression of IL-6, the
relative local concentration of IL-6 also appears to be of great
importance, dictating the action of IL-6 on the target tissue. High
local concentrations such as those observed in the satellite cell
compartment (or niche) following damaging exercise may confer
a positive effect on these cells, promoting the induction of the
cell-cycle through the targeted up-regulation of cMyc and cyclin
D1 (McKay et al., 2009). While a relatively modest temporal
increase in IL-6 in the circulation (presumably released from the
working muscle) may serve to sensitize the muscle to IL-6 by
increasing both IL-6Rα and GP130 mRNA, a chronic elevation
IL-6 may be detrimental to the same pathway (McKay et al.,
2009). Therefore, the local concentration of IL-6 in the vicinity of
the satellite cell niche may be of more relevant for the satellite cell
response than the systemic concentration of IL-6. This concept of
compartmentalization of the IL-6 response may contribute to the
pleiotropic effect of IL-6 on skeletal muscle.
Myostatin
Myostatin is a member of the transforming growth factor-β
(TGF-β) superfamily and acts as a potent negative regulator of
skeletal muscle growth (McPherron et al., 1997; McPherron and
Lee, 2002). McPherron et al. (1997) were the first to characterize
the phenotypic response to a myostatin gene mutation in mice.
They showed that inhibition or mutation of the myostatin
gene resulted in mice with 2–3 fold greater muscle mass as
compared to wild-type mice (McPherron et al., 1997). This
initial study was soon followed by other reports that naturally
occurring myostatin mutations are accompanied by excessive
muscle fiber hypertrophy/hyperplasia as observed in double-
muscled cattle, sheep and dogs (Grobet et al., 1997; Kambadur
et al., 1997; Clop et al., 2006; Mosher et al., 2007). In humans,
a single case study has been published in which a new born
was identified as a carrier of a myostatin null mutation, after
being noted to have an unusual amount of muscle mass at
birth (Schuelke et al., 2004). Multiple mechanistic pathways
through which myostatin is able to regulate skeletal muscle
growth have already been identified. Myostatin has been shown
to induce muscle wasting by acting on the ubiquitin proteolytic
system, evidenced by the myostatin induced up-regulation of
genes like atrogin-1, FoxO1, and MuRF-1 (McFarlane et al.,
2006). Secondly, myostatin is known to affect muscle mass by
regulating myogenesis. In vitro experiments have shown that
myostatin blocks myoblast proliferation (Thomas et al., 2000;
Taylor et al., 2001) and differentiation by the down regulation of
MyoD (Langley et al., 2002) and up-regulation of p21, a regulator
of cell cycle progression (McFarlane et al., 2011). In addition,
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myostatin inhibits satellite cell proliferation and self-renewal
(McCroskery et al., 2003). In contrast, in vivo animal models have
reported discrepant findings. Whereas, some do (McCroskery
et al., 2003; McFarlane et al., 2011) others do not (Amthor
et al., 2009; Wang and McPherron, 2012) show that satellite
cell proliferation and pool size are significantly higher in muscle
tissue from myostatin knock-out compared with wild-type mice.
In addition, pharmacological inhibition of the myostatin/activin
A pathway has been demonstrated to induce muscle hypertrophy
with little to no fusion of satellite cells to the myofibers (Lee et al.,
2012). These in vitro and animal studies do not, however, address
the potential role of myostatin during muscle fiber growth in a
more physiological scenario, such as in response to a single bout
of exercise or during adaptation to prolonged exercise training in
humans. We have previously shown that myostatin is expressed
in human skeletal muscle satellite cells (McKay et al., 2012;
Snijders et al., 2014b,c). During resting conditions approximately
80% of the satellite cell pool is co-localized with myostatin. In
addition, by the utilization of the single-bout-exercise model we
were able to show that the number of myostatin+ satellite cells
in both type I and type II muscle fibers decreases substantially,
the timing of which is consistent with an increase in the number
of MyoD+ satellite cells and number of satellite cells in the S-
phase of the cell cycle (McKay et al., 2012; Snijders et al., 2014b,c).
Together, in vivo human, animal and cell studies suggest that
myostatin is a powerful negative regulator of muscle growth and
is therefore possibly critical in the muscle fiber adaptive response
to a stimulus like exercise training. However, whether this effect
is, at least in part, regulated through muscle satellite cells remains
to be further elucidated.
SATELLITE CELLS AND MUSCLE FIBER
HYPERTROPHY
Although it has been well-established from both animal and
human studies that satellite cells are essential in muscle fiber
repair and regeneration, there is still an ongoing debate on the
importance of satellite cells during muscle fiber hypertrophy.
Early γ-irradiation studies suggested that muscle fiber growth
in mice is virtually non-existent when satellite cells are ablated
(Rosenblatt and Parry, 1992, 1993). However, it was later argued
that the cellular specificity of γ-irradiation was too low to truly
assess the absolute requirement of satellite cells in overload
induced muscle fiber hypertrophy (McCarthy et al., 2011).
In response, McCarthy et al. (2011) used a mouse model to
conditionally and specifically ablate Pax7+ cells to re-evaluate
the hypothesis that satellite cells are required to support skeletal
muscle hypertrophy. They reported that in normal, non-satellite
cell depleted muscle (i.e., sham condition), overload induced
muscle fiber hypertrophy was accompanied by the contribution
of new myonuclei from satellite cells (McCarthy et al., 2011).
However, muscle fiber hypertrophy (during 2 weeks of overload)
was found to be similar in the satellite cell ablated condition, in
which satellite cells were depleted by greater than 90% (McCarthy
et al., 2011). As such, the authors concluded that satellite cells
are not essential to support hypertrophy inmouse skeletal muscle
(McCarthy et al., 2011). However, Fry et al. (2014b) observed that
exposing these genetically modified mice to prolonged overload
(8 weeks) compromises muscle fiber hypertrophy. In addition,
the authors suggested that the substantial increase in extracellular
matrix during this period of overload may contribute to the
impaired muscle fiber growth response (Fry et al., 2014b). Taken
together, these data indicate that under specific experimental
conditions, the existing myonuclei have the intrinsic ability
to increase their capacity to such an extent that additional
myonuclei are not required to support muscle fiber growth
but this growth appears to be unsustainable. In other words,
satellite cells do appear to be required to support extensive
muscle fiber hypertrophy in response to an anabolic stimulus
(Fry et al., 2014b). Although these studies address an intriguing
question in an experimental (non-physiological) model of muscle
biology, translating these results to human physiology remains
a challenge. The reality is that these experimental models are
important as they provide proof of principle for biological
phenomena. They do not, however, establish that these principles
are relevant under physiological conditions. Most human studies
are descriptive, demonstrating correlations between changes in
myonuclear content, satellite cell number, and muscle fiber size
in response to an anabolic stimulus. Nonetheless, such studies
are crucial in understanding the role of satellite cell content and
function in skeletal muscle fiber hypertrophy in an in vivo human
setting. A growing number of studies have now consistently
demonstrated that muscle fiber hypertrophy is accompanied by a
concomitant increase in satellite cell and/or myonuclear content
during prolonged resistance type exercise training (Kadi and
Thornell, 2000; Kadi et al., 2004c; Olsen et al., 2006; Petrella et al.,
2006; Mackey et al., 2007a, 2011a,b; Verney et al., 2008; Verdijk
et al., 2009, 2014; Menon et al., 2012; Leenders et al., 2013; Suetta
et al., 2013; Farup et al., 2014b). In addition, a positive correlation
between the increase in muscle fiber size and increase in satellite
cell content in response to prolonged resistance type exercise
training in healthy young and elderly men and women has been
well-established (Petrella et al., 2006; Verdijk et al., 2010, 2014;
Mackey et al., 2011b; Bellamy et al., 2014). This would suggest
that satellite cells do play an important role in muscle fiber
hypertrophy in response to a growth stimulus in human muscle,
irrespective of whether they are “required” or not. Interestingly,
Bellamy et al. (2014) have recently shown that the acute changes
in satellite cell content in response to a single bout of resistance
type exercise are related to long-term changes in skeletal muscle
mass and cross-sectional area following 16 weeks of resistance
type exercise training in healthy, young men.
Alternatively, we have recently hypothesized that satellite
cells may also play an important role in non-hypertrophic
skeletal muscle remodeling (Joanisse et al., 2013, 2015). We
have demonstrated that 6 weeks of high intensity sprint interval
or moderate intensity continuous aerobic exercise does not
result in changes in type I or type II muscle fiber size and/or
satellite cell content in untrained healthy young men and women
(Joanisse et al., 2013, 2015). Interestingly however, the number
of proliferating satellite cells increased significantly in type I
and type II muscle fibers in response to both exercise programs
(Joanisse et al., 2015). Furthermore, a significant increase in the
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percentage of hybrid fibers (i.e., fibers that are co-expressing both
myosin heavy chain I and II) after high intensity sprint interval
training was accompanied by a significant increase in the number
of satellite cells associated with these hybrid fibers (Joanisse et al.,
2013). This increase in the number of satellite cells associated
with hybrid fibers following training may be required in order
for fast-to-slow muscle fiber transitions to occur in response to
prolonged exercise training. However, others have shown that a
shift in fiber type distribution can occur independent of changes
in satellite cell content following 12 weeks of aerobic training in
healthy young men (Fry et al., 2014a). In addition, several animal
studies have reported that muscle fiber type transition can occur
in the absence of satellite cell activation (Rosenblatt and Parry,
1993; Adams et al., 2002; Fry et al., 2014b). Differences between
studies may be explained by the different models (i.e., exercise
modality, volume, and/or intensity) used to evaluate satellite cell
function in muscle fiber adaptation. The precise role of satellite
cells in non-hypertrophic skeletal muscle remodeling remains
largely to be elucidated. It does, however, open a wide range of
new research questions on the role of satellite cells in skeletal
muscle remodeling.
Taken together, evidence from human studies strongly
suggests that satellite cells play a key role in skeletal muscle
fiber hypertrophy in humans. The premise that satellite cells
may also play an important role in other processes of skeletal
muscle fiber remodeling is thought-provoking and warrants
future studies. In addition, more in vivo human studies are
needed to further decode the factors that trigger satellite cells
from quiescence to their activated state. As impairments in
satellite cell activation have been hypothesized to play a key
role in the blunted skeletal muscle fiber growth response after
a stimulus like exercise training in healthy elderly and/or more
clinically compromised populations, the identification of these
specific factors may prove to be paramount in the potential
development of novel intervention strategies to more effectively
combat the loss of muscle mass associated with aging and/or
disease.
SKELETAL MUSCLE AGING
Aging is accompanied by a progressive loss of skeletal muscle
mass, also known as sarcopenia. At the muscle fiber level, this
loss of muscle mass is mainly characterized by type II muscle
fiber atrophy. In addition, we (Verdijk et al., 2009, 2010, 2012,
2014; McKay et al., 2012, 2013; Leenders et al., 2013) as well as
others (Verney et al., 2008; Carlson et al., 2009; Suetta et al., 2013;
Mackey et al., 2014) have consistently shown that type II muscle
fiber atrophy in aged muscle is accompanied by a type II muscle
fiber type specific reduction in satellite cell content. Although
satellite cells are considered to be the main (or only) source
of new myonuclei, whether they are a key regulator of skeletal
muscle mass maintenance throughout life remains debatable.
Based on a study in animals showing that a decline in satellite
cell content precedes age-related muscle fiber atrophy (Brack
et al., 2005) and the observation that satellite cell content has
been shown to be a strong predictor of muscle fiber size in older
adults (Verdijk et al., 2010), it has been hypothesized that an
age-related decline in type II muscle fiber satellite cell content
may lead to a reduced capacity for muscle fiber maintenance,
leading to specific type II muscle fiber atrophy typically observed
in aged muscle (Snijders et al., 2009). This notion has, however,
recently been challenged by work using a conditional model of
satellite cell ablation (Fry et al., 2015). In this animal study,
±85% of the satellite cells were depleted from muscle in the
experimental group, thereby severely impairing muscle fiber
regeneration over the entire life-span as compared to a control
group. Following 24 months, significant atrophy was apparent
in both the experimental and control animals (Fry et al., 2015).
This suggests that the loss of satellite cells through-out adulthood
does not accelerate sarcopenia in aging mice (Fry et al., 2015).
In addition, no difference was observed in muscle specific force
and raw grip strength between the two groups. Yet, satellite cell
depletion did result in a significant accumulation of extracellular
matrix proteins throughout life (Fry et al., 2015). An important
consideration in the interpretation of these results is that themice
were sedentary throughout their lives, which does not represent
a normal physiological condition. The fact is that mice living in a
cage from birth to death is a level of sedentary behavior that far
exceeds a sedentary lifestyle in a human. Moreover, the recovery
from major life events, like sickness or injury, which is typically
observed throughout life in humans, is not accounted for in this
model and has been suggested to be of major importance in the
progression of sarcopenia (Baumgartner et al., 1998; Paddon-
Jones et al., 2008; Wall et al., 2013). Thus, the translation of these
results to real life settings in a human model remains a challenge.
Since it is impossible to monitor a human throughout
the entire lifespan, to study the mechanisms underlying the
loss of muscle mass with age, studies in humans are mostly
restricted to cross-sectional research designs (as discussed above)
and/or more short-term models of muscle fiber atrophy. Limb
immobilization is a model extensively used, which allows for
the assessment of short-term skeletal muscle fiber atrophy in a
longitudinal fashion. The use of short term disuse muscle fiber
atrophy models may be of great clinical importance as it is
likely that the accumulation of short periods of muscle disuse
that occur throughout an individual’s lifespan may contribute
significantly to the etiology of age-related sarcopenia. So far,
few studies have assessed the potential role of satellite cells in
the development of (disuse) muscle fiber atrophy in humans.
Satellite cell pool size has been reported to remain unchanged
when muscle fiber atrophy was induced by 5 or 14 days of single
leg immobilization in both young (Carlson et al., 2009; Snijders
et al., 2014a; Dirks et al., 2014b) and older men (Carlson et al.,
2009; Suetta et al., 2013). Others have even reported a significant
increase in the number of satellite cells in both type I and type
II muscle fibers in response to disuse atrophy in healthy young
males (Suetta et al., 2013). In this study by Suetta et al. (2013),
2 weeks of single leg immobilization was followed by 4 weeks of
reloading in both young and older men. Type I and type II muscle
fiber size returned back to baseline and was accompanied by a
significant increase in satellite cell number during the 4 weeks of
reloading in young men (Suetta et al., 2013). In contrast, muscle
fiber size did not recover and satellite cell content remained
low during the reloading period in older men. The authors
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FIGURE 3 | Schematic representation of normal (A) and aged (B) myogenic program in response to an anabolic stimulus. In adult skeletal muscle, satellite
cells are typically in a quiescent state and reside in a niche between the sarcolemma and basal lamina of their associated muscle fiber. Upon stimulation, i.e., following
exercise, satellite cells become activated, and start to proliferate. Following proliferation, satellite cells differentiate, and either fuse with each other forming new
myofibers, fuse to an existing muscle fiber donating their nucleus to the fiber thereby allowing muscle fiber hypertrophy, or return back to their quiescent state
(self-renewal). The progression of the satellite cell through the myogenic program is orchestrated by the up- or down-regulation of the paired box transcription factor
Pax7 and the myogenic regulatory factors (e.g., Myf5, MyoD, MRF4, and Myogenin). A number of factors [e.g., hepatocyte growth factor (HGF), myostatin (Mstn),
Notch/Delta1, interleukin-6 (IL-6), mechano growth factor (MGF), and insulin like growth factor-1 (IGF-1)] have been identified to have a positive/negative influence on
the different stages of the myogenic program. In aged skeletal muscle the number of muscle satellite cells is reduced and the microstructure of the niche is altered. An
increased subclinical level of inflammation and increased Mstn in the circulation has been suggested to impair or delay the proliferative drive of satellite cells in
response to anabolic stimuli. Alternatively, it has been hypothesized that in aged muscle the activated satellite cells may also commit directly to differentiation, i.e.,
skipping the proliferation phase. Studies suggest that aged satellite cells are more likely to differentiate to an alternative cell fate (e.g., adipocytes, fibroblasts) or are
directed toward apoptosis, thereby reducing the number of myonuclei formed to allow adequate repair and/or hypertrophy of the muscle fiber. Increased systemic
levels of Mstn reduces the fusion of newly formed myonuclei, impairing muscle repair and regeneration, and impairs fusion of myonuclei to existing muscle fibers,
limiting muscle fiber growth in aged skeletal muscle.
suggest that a reduced sensitivity to certain growth factors, that
also regulate satellite cell function, may explain this impaired
recovery from short-term physical inactivity in older men (Suetta
et al., 2013). In contrast, animal studies have demonstrated that
satellite cells are not essential in the re-growth of skeletal muscle
following 2 week of hindlimb suspension (Jackson et al., 2012).
In this study, the number of myonuclei remained unchanged
during hindlimb suspension and reloading. In other words,
myonuclear domain size (i.e., the ratio between muscle fiber
size and myonuclear content) was able to contract during short-
term muscle fiber atrophy and expands again during reloading
making additional myonuclei, and thereby satellite cell activation
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and/or proliferation, not a requirement. Likewise, in human
skeletal muscle, myonuclear number does not appear to be lost
in response to short-term (5–14 days) limb immobilization in
both young and older men (Dirks et al., 2014a,b; Snijders et al.,
2014a). However, mixed results have been reported during aging.
Although the vast majority of studies in humans do not observe
a loss in myonuclear number during age-related muscle fiber
atrophy (Kadi et al., 2004a; Dreyer et al., 2006; Petrella et al.,
2006; Verdijk et al., 2007; Mackey et al., 2014; Karlsen et al.,
2015), this has been suggested to be mainly related to the lack of
fiber type specific data and the number and age of participants
included. In the largest (N = 152) cross-sectional study of
healthy men to date, we have recently shown that type II muscle
fiber myonuclear number was not different between healthy
young (18–49 years) and older men (50–69 years), but was
significantly lower in healthy elderly (70> years) men (Verdijk
et al., 2014). Furthermore, it is important to note that most
studies report changes in myonuclear number per fiber type as
an average of the entire muscle biopsy sample, but, previous
animal studies show that loss of myonuclear content may be
differentially regulated in small compared with large muscle
fibers (Brack et al., 2005). Conversely, a more recent study was
not able to replicate these results in human skeletal muscle
(Karlsen et al., 2015). The former may, however, be explained
by the relative young age (66 ± 4 years) of older men included
in this study. It would be interesting to observe whether similar
results would be obtained in older, frail and/or more clinical
populations.
During more severe pathological conditions of muscle
wasting, like Duchenne or myotonic muscular dystrophy,
exhaustion of the satellite cell pool has been hypothesized to play
an important role in the inability to offset degenerative events in
animalmodels (Decary et al., 2000; Luz et al., 2002; Thornell et al.,
2009). Although this hypothesis has been challenged by more
recently published cross-sectional data from human muscular
dystrophy studies (Kottlors and Kirschner, 2010; Bankole et al.,
2013), there is no indication that exhaustion of the satellite cell
pool occurs with aging in humans. For example, no difference
in skeletal muscle telomere length has been observed between
healthy young and elderly men and women (Ponsot et al., 2008).
Accordingly, a lower satellite cell pool size in type II muscle
fibers, typically observed in human agedmuscle, does not prevent
muscle fiber hypertrophy in healthy elderly men and women in
response to prolonged resistance type exercise training (Mackey
et al., 2007a; Verney et al., 2008; Verdijk et al., 2009, 2010,
2014; Leenders et al., 2013). Furthermore, satellite cell content
has been shown to be similar between age-matched healthy
untrained elderly and masters endurance athletes (Mackey et al.,
2014).
Aside from satellite cell content, impairments in satellite
cell function have also been suggested to be an important
contributing factor to the loss of muscle mass with increasing age
(Figure 3). For example, under homeostatic conditions fibroblast
growth factor 2 (FGF2) expression is considerably increased
in the aged stem cell niche, causing a down-regulation of
Sprouty1 in quiescent satellite cells (Chakkalakal et al., 2012).
Sprouty1 is a known negative regulator of FGF2 signaling and
has previously been shown to be required for the return to
quiescence and self-renewal of satellite cells during muscle fiber
regeneration (Abou-Khalil and Brack, 2010; Shea et al., 2010).
Hence, it has been suggested that the dysregulation of the
FGF2/Sprouty1 signaling cascade drives a subset of satellite cells
to exit the quiescent state and lose their self-renewal capacity, and
thereby diminishing muscle regeneration in aged mouse muscle
(Chakkalakal et al., 2012). Likewise, impaired up-regulation of
Notch ligand Delta 1 in aged satellite cells impairs satellite
cell activation, proliferation, and muscle repair following injury
(Conboy et al., 2003, 2005; Wagers and Conboy, 2005). Notch
signaling has also been implicated in satellite cell homeostasis,
as reduced Notch signaling leads to myogenic differentiation,
bypassing self-renewal, eventually resulting in the loss of satellite
cells (Bjornson et al., 2012; Mourikis et al., 2012). Furthermore,
others have also recently shown that in agedmice, resting satellite
cells lose reversible quiescence due to switching to an irreversible
dormant state, caused by the de-repression of p16INK4a
(Sousa-Victor et al., 2014).
A recent publication in Science reported that systemic levels
of growth differentiation factor 11 (GDF11) were substantially
reduced with age (Sinha et al., 2014). In the same report dramatic
positive effects were observed on satellite cell number, muscle
fiber regeneration, size, and function when recombinant GDF11
was administered for 28 days to aged mice (Sinha et al., 2014).
These results were rather surprising given the fact that, as a TGF-
β familymember, GDF11 is highly related tomyostatin. The latter
which is known to be a direct inhibitor of muscle fiber growth
(McPherron et al., 1997;McPherron and Lee, 2002). It was argued
that the specificity of the antibody used in this study was too
low to discriminate between GDF11 and myostatin. In response,
Egerman et al. (2015) established a specific immunoassay to
measure only changes in GDF11 protein, and demonstrated
that in both animal and humans GDF11 was actually increased
with aging. Furthermore, they showed that systemic injection
of GDF11 impairs satellite cell proliferation and differentiation,
resulting in decreased muscle fiber regeneration in mice. This
work appears to be more in line with other previous publication
on the inhibitory function of GDF11 on muscle fiber growth
and regeneration (Gamer et al., 2001; Souza et al., 2008; Lee and
Lee, 2013). Altogether, these studies clearly suggest that specific
signaling proteins cause a disruption of satellite cell activation,
proliferation, and/or differentiation with aging during muscle
fiber repair and remodeling.
Previous animal studies have also shown that extrinsic
signals in the satellite cell micro-environment are important
in the age-related dysregulation of satellite cells during muscle
fiber regeneration. To investigate whether muscle regeneration
from old animals could be restored to a more youthful state
by environmental exposure, studies have utilized experimental
models including heterochronic (young-to-old or old-to-young)
tissue transplantation and heterochronic parabioses, whereby
the systemic circulation of two animals are joined together.
Grafting muscle fragments from aged animals onto young
muscle beds has been observed to result in equivalent muscle
regeneration when compared with young muscle autografts
(Gutmann and Carlson, 1976; Carlson and Faulkner, 1989;
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Roberts et al., 1997). Furthermore, Conboy et al. (2005) have
demonstrated that muscle satellite cells from old mice can be
rejuvenated by exposure to a young environment, by means of
heterochronic parabioses. In addition, in this model satellite cells
from the young animals also adopted a more aged molecular
and functional state, indicating that the systemic environment
is a major determinant of the “functional age” of the cell (Brack
et al., 2007; Rando and Chang, 2012). Similar results have been
reported by in vitro cell studies, where serum from young animals
has been shown to rejuvenate the proliferative capacity of aged
satellite cells (Carlson and Faulkner, 1989; Brack et al., 2007).
In contrast, discrepant findings have been reported in human
myoblasts. Whereas, some do (Carlson et al., 2009) others do
not (George et al., 2010a) show that young serum can restore
in vitro cell function of aged human myoblasts. Differences in
methodology used to assess satellite cell proliferation and serum
concentrations may, in part, explain these discrepant findings in
human myoblasts, but future studies are warranted to further
clarify these dissimilarities.
Whether or not age-related impairments in satellite cell
function may have functional consequences for muscle fiber
growth remains to be resolved in both animal as well as human
models. Recent studies in animals have reported discrepant
findings on the importance of satellite cell function during
overload induced muscle fiber growth in aged mice. In a study
where synergistic denervation was used to overload the plantaris
muscle for 6 weeks in aged mice, impaired but significant
muscle fiber hypertrophy was observed to be correlated to
reduced satellite cell number (Ballak et al., 2015). In contrast,
a study by Lee et al. (2015) reported no difference in muscle
fiber hypertrophy after 2 weeks of synergistic ablation induced
overload between mice in which satellite cells were depleted from
skeletal muscle and wild-type controls. Although myonuclear
and satellite cell content increased significantly in wild-typemice,
this study reported no change in muscle fiber size during the 2
weeks of overload (Lee et al., 2015). These discrepancies between
studies may be explained by the different techniques used to
induce and/or duration of overload applied. More importantly,
as in mice it has been reported that muscle satellite cells are
only essential during extensive muscle fiber growth, it would
be interesting to known whether in aged muscle satellite cell
depleted mice similar results would be obtained during a more
prolonged period of overload. In human skeletal muscle, the
effect of age on satellite cell function is primarily investigated
using acute damaging or non-damaging exercise as a form of
stress to mobilize the satellite cell population. Studies have
shown that expansion of the satellite cell pool is blunted during
recovery from a single bout of eccentric (Dreyer et al., 2006;
Walker et al., 2012) and/or resistance (McKay et al., 2012,
2013; Snijders et al., 2014c) exercise in healthy older when
compared with young men (see Tables 1, 2). Moreover, we have
shown that the blunted expansion of the satellite cell number
during post-exercise recovery canmainly be attributed to satellite
cells associated with type II muscle fibers (McKay et al., 2012;
Snijders et al., 2014c). Whether this may, in part, explain the
reduced capacity of older adults to increase skeletal muscle mass
during prolonged resistance type exercise training remains to
be fully established (Kosek et al., 2006; Petrella et al., 2006).
Nevertheless, increasing our understanding on the underlying
mechanisms of this impaired type II muscle fiber type specific
satellite cell response during post-exercise recovery in humans
is critical as this may determine whether exercise, nutritional
and/or pharmaceutical interventions should specifically target
these cells to combat sarcopenia.
Recent studies have suggested a number of factors that may, in
part, explain the reduced satellite cell proliferative drive during
post-exercise recovery observed with aging in human skeletal
muscle (Figure 3). As discussed above, IL-6 has been reported to
play a major role in the activation of satellite cells in response
to muscle damage or hypertrophic stimuli in human skeletal
muscle (Serrano et al., 2008). However, chronically elevated
levels of IL-6 are associated with pro-inflammatory and muscle
wasting conditions such as cachexia (Roubenoff, 1999, 2003).
The infusion of IL-6 in mice leads to a catabolic environment,
promote muscle wasting, and impairs muscle fiber growth
(Haddad et al., 2005; Bodell et al., 2009). In humans, it is well-
established that circulating IL-6 levels are systemically elevated in
healthy elderly individuals (Wei et al., 1992; Ershler et al., 1993;
Hager et al., 1994; McKane et al., 1994; Cohen et al., 1997; Harris
et al., 1999; Visser et al., 2002; Bruunsgaard and Pedersen, 2003;
Ferrucci et al., 2005; Pereira et al., 2009; McKay et al., 2013). In
addition, age-related increases in serum IL-6 are associated with
lower muscle strength and muscle mass in older adults (Visser
et al., 2002; Pereira et al., 2009). Furthermore, in human skeletal
muscle IL-6 mRNA and protein expression is significantly higher
in healthy elderly compared with young individuals (McKay
et al., 2013). We have previously shown a delay in the induction
of IL-6 in satellite cells in response to a single bout of resistance
type exercise in older adults (McKay et al., 2013). This may
appear counterintuitive with the whole muscle and systemic
response of IL-6, which has been reported to be more rapid and
robust in older compared with young men during regeneration
(McKay et al., 2013). However, basal muscle SOCS3 expression is
substantially higher in old compared with young skeletal muscle
(Leger et al., 2008; Alvarez-Rodriguez et al., 2012; McKay et al.,
2013). The main negative regulator of IL-6/STAT3 signaling is
SOCS3, which is induced by pSTAT3 as a negative feedback
mechanism (Rawlings et al., 2004). Subsequently, chronically
elevated IL-6 levels in older adults may impair the normal IL-
6 response, and the sensitivity of satellite cells to IL-6 (McKay
et al., 2013). This suggestion is further supported by elevated
basal levels of SOCS3 protein and blunted increases in pSTAT3
in type II muscle fiber associated satellite cells of older adults
3 h post-exercise (McKay et al., 2013). This phenomenon is also
observed in obese patients with type-2 diabetes mellitus where
chronically elevated circulating IL-6 levels were associated with
an impaired satellite cell response and impaired IL-6 receptor and
STAT3/SOCS3 signaling cascades (Scheele et al., 2012). Therefore
alterations in cytokine signaling in aging muscle may strongly
influence satellite cell function.
Myostatin has been suggested to play a crucial role in the
development of various muscle wasting conditions. Circulating
levels of myostatin and/or expression in muscle have been
reported to be elevated in animal models of cachexia (Costelli
Frontiers in Physiology | www.frontiersin.org 13 October 2015 | Volume 6 | Article 283
Snijders et al. Satellite cells and muscle plasticity
et al., 2008; Zhou et al., 2010), chronic kidney disease (Zhang
et al., 2011), glucocorticoid administration (Lang et al., 2001),
burn injury (Lang et al., 2001), and also during mechanical
unloading (Carlson et al., 1999), and spaceflight (Lalani et al.,
2000; Allen et al., 2009). Similar changes in myostatin expression
have been observed in patients with cancer (Aversa et al., 2012),
HIV/aids (Gonzalez-Cadavid et al., 1998), COPD (Plant et al.,
2010; Hayot et al., 2011; Ju and Chen, 2012), renal failure (Sun
et al., 2006), and heart failure (George et al., 2010b; Breitbart
et al., 2011; Gruson et al., 2011). In healthy individuals, myostatin
levels in the circulation, and/or expression in muscle have been
reported to increase in response to prolonged bed rest (Reardon
et al., 2001). In addition, elderly men and women have been
shown to express higher levels of myostatin protein in the
circulation (Yarasheski et al., 2002) and in skeletal muscle (McKay
et al., 2012) compared with younger controls. In contrast, no
difference exists in the proportion of myostatin+ satellite cells
between healthy young and elderly men in the basal state (McKay
et al., 2012; Snijders et al., 2014c). Yet, the decline in the
number of myostatin+ satellite cells in response to an anabolic
stimuli (e.g., single bout of resistance exercise) is significantly
greater in healthy young compared with elderly men (McKay
et al., 2012; Snijders et al., 2014c). The greater proportion of
myostatin+ satellite cells during post-exercise recovery in old
muscle was associated with a reduction in satellite cell activation
and proliferation, as verified by the lack of progression of satellite
cells into the S-phase of the cell cycle (McKay et al., 2012).
Furthermore, the presence of myostatin was more prevalent in
satellite cells residing in type II muscle fibers in older adults,
which was associated with a delayed increase in the number of
type II muscle fiber satellite cells in response to exercise (McKay
et al., 2012; Snijders et al., 2014c). Hence, it was hypothesized that
myostatin may inhibit satellite cell activation and proliferation
to a greater degree in aged muscle, delaying the muscle adaptive
response to the anabolic stimulus (McKay et al., 2012; Snijders
et al., 2014c).
It would be of great interest to observe whether, for example,
the irreversible dormant state of satellite cells in aged muscle
observed in animals (Chakkalakal et al., 2012; Sousa-Victor et al.,
2014) may explain the impaired satellite cell function observed
during recovery from an anabolic stimulus and/or a period of
disuse in healthy elderly people. Alleviating a pre-senescent state
and/or blunted satellite cell activation response after a single
exercise session in aged muscle may represent a key target in the
development of future intervention strategies to more effectively
counteract the progressive loss of muscle mass with aging. Future
research should aim to determine the underlying mechanisms of
the transition of quiescent satellite cells to their activated state in
both young and elderly people in response to different anabolic
stimuli.
Although it appears muscle satellite cell dysfunction is a
precursor to the onset of sarcopenia, this idea remains debatable.
However, it has been demonstrated that exercise training can
mitigate at least some of the negative effects of aging on
satellite cell number (Verdijk et al., 2009; Leenders et al.,
2013) and particularly skeletal muscle as a whole (Melov et al.,
2007; Lanza et al., 2008; Aagaard et al., 2010). Currently,
research efforts are underway to elucidate whether exercise
training actually confers a survival benefit to the satellite
cells and whether exercise can restore satellite cell function
either directly via modification of the proteasome or through
epigenetic modifications (or both). There is an emerging body
of literature that focuses on rejuvenating stem cell function
through epigenetic reprogramming (recently reviewed by Rando
and Chang, 2012). Although this area appears to be promising for
the future, much work needs to be done to define how epigenetic
states of young and old satellite cells differ and if modifications
are inducible in a safe and effective manner.
CONCLUSION
Over the past decade, considerable advances in our
understanding of skeletal muscle satellite cells during muscle
fiber repair and remodeling in human skeletal muscle have been
made. Evidence from in vivo human studies suggests that satellite
cells play a key role, not only in growth and hypertrophy but
also in adaptation and remodeling in response to damaging and
non-damaging exercise. Yet, it is clear that we are only at the
verge of deciphering the regulatory factors underlying activation,
proliferation and differentiation of satellite cells during muscle
fiber repair and/or remodeling in humans. Mounting evidence
indicates that aging has a profound effect on the regulation of
satellite cell number and function in human skeletal muscle. As
our understanding of age-related pathophysiology of satellite
cells evolves the potential to treat age-related sarcopenia in
a meaningful way may become a reality. It is clear, however,
that examining the role of niche elements and circulating
factors in addition to the satellite cell is essential in order to
design therapeutic strategies to ensure potential successful and
efficacious treatment of sarcopenia.
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